Faruqi and Faruqui, LLP Logo
Share this page

Vitamin Shoppe, Inc. (VSI)

NYSE:VSI

Summary

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Vitamin Shoppe, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Vitamin Shoppe, Inc. (“Vitamin Shoppe” or the “Company”) (NYSE:VSI) of the October 27, 2017 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Vitamin Shoppe stock or options between March 1, 2017 and August 8, 2017 and would like to discuss your legal rights, please fill out the form below.  There is no cost or obligation to you.  You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. 

The lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all those who purchased Vitamin Shoppe common stock between March 1, 2017 and August 8, 2017 (the “Class Period”).  The case, Aguilar v. Vitamin Shoppe, Inc. et al, No. 2:17-cv-06454 was filed on August 28, 2017.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Vitamin Shoppe’s retail segment was continuing to significantly decline, as its ongoing “reinvention plan” was not meeting with success; (2) ongoing changes to Vitamin Shoppe’s operating plan brought about through the “reinvention plan” had already rendered the more than $168 million in goodwill being carried on Vitamin Shoppe's books for the retail segment impaired and Vitamin Shoppe was improperly delaying recognizing that impairment charge; (3) and as a result, Vitamin Shoppe lacked a reasonable basis for their positive statements about its financial prospects.

Specifically, on May 10, 2017, Vitamin Shoppe released its first quarter 2017 financial results and slashed its fiscal 2017 guidance by 45%, yet claimed the “reinvention plan” was still succeeding.  On this news, Vitamin Shoppe’s share price fell from $19.00 per share on May 9, 2017 to a closing price of $12.70 on May 10, 2017—a $6.30 or a 33.16% drop.

Then, on August 9, 2017, Vitamin Shoppe announced that it was taking a $168.1 million impairment charge on the goodwill being carried on its books associated with its retail segment.  As a result, the Company would report a “GAAP loss per share of $6.73” in its second quarter 2017.  On this news, Vitamin Shoppe’s share price fell from $9.60 per share on August 8, 2017 to a closing price of $6.10 on August 9, 2017—a $3.50 or a 36.46% drop.

Request Information

Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you.

  • Case:
    Vitamin Shoppe, Inc. (VSI)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 08/29/2017

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.